Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know

Radioembolization using beta-emitting yttrium-90 microspheres is being increasingly used for the treatment of primary and metastatic liver cancers. It is a form of intra-arterial brachytherapy which delivers intense radiation to liver tumors with little embolic effect; this mode of action results in unique post-treatment imaging findings. It is important to understand these imaging findings to avoid misinterpretation of tumor response and to determine further management of the disease. Herein, we discuss the current concepts for assessing tumor response, common post-treatment imaging features, and associated complications following radioembolization.

• Publication year

  2018

• Venue

  Korean Journal of Radiology

• Publication date

  2018-02-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.3348/kjr.2018.19.2.209PMID 29520178PMCID 5840049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion‐weighted imaging in an orthotopic hepatocellular carcinoma xenograft model

  2017cited by this paper
• Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions.

  2017cited by this paper
• Imaging Patterns of Intratumoral Calcification in the Abdominopelvic Cavity

  2017cited by this paper
• Prophylactic Temporary Occlusion of the Cystic Artery Using a Fibered Detachable Coil During 90Y Radioembolization

  2017cited by this paper
• Radioembolization for the treatment of hepatocellular carcinoma

  2017cited by this paper
• Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review

  2017cited by this paper
• Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy

  2017cited by this paper
• Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.

  2016cited by this paper
• Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review

  2016influential reference
• Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings.

  2016cited by this paper
• Radioembolization: Is Prophylactic Embolization of Hepaticoenteric Arteries Necessary? A Systematic Review

  2016cited by this paper
• 90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes

  2016cited by this paper
• Microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies.

  2016cited by this paper
• Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization

  2016cited by this paper
• Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality

  2016cited by this paper
• The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases

  2016cited by this paper
• Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma

  2016cited by this paper
• Transarterial Therapies for Hepatocellular Carcinoma

  2016cited by this paper
• Hepatic imaging following intra-arterial embolotherapy

  2016influential reference
• Computed tomography imaging assessment of postexternal beam radiation changes of the liver.

  2016cited by this paper
• Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.

  2015cited by this paper
• Role of C-Arm Cone-Beam CT in Chemoembolization for Hepatocellular Carcinoma

  2015cited by this paper
• Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver

  2015cited by this paper
• 90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments

  2015cited by this paper
• Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres

  2015cited by this paper
• Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.

  2015cited by this paper
• CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review

  2015cited by this paper
• (90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.

  2015cited by this paper
• PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response

  2015cited by this paper
• Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.

  2014cited by this paper
• Stereotactic Body Radiotherapy-Induced Arterial Hypervascularity of Non-Tumorous Hepatic Parenchyma in Patients with Hepatocellular Carcinoma: Potential Pitfalls in Tumor Response Evaluation on Multiphase Computed Tomography

  2014influential reference
• Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis

  2014cited by this paper
• Side Effects of Yttrium-90 Radioembolization

  2014cited by this paper
• Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy

  2014cited by this paper
• Radiation-induced cholecystitis after hepatic radioembolization: do we need to take precautionary measures?

  2014cited by this paper
• Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors.

  2014cited by this paper
• Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.

  2014cited by this paper
• Yttrium-90 radioembolization of liver tumors: what do the images tell us?

  2014cited by this paper
• Hepatic Radioembolization as a Bridge to Liver Surgery

  2014cited by this paper
• Radioembolization and the Dynamic Role of 90Y PET/CT

  2014cited by this paper
• Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.

  2014cited by this paper
• Serious hepatic complications of selective internal radiation therapy with yttrium‐90 microsphere radioembolization for unresectable liver tumors

  2014cited by this paper
• Prognostic factors and prevention of radioembolization‐induced liver disease

  2013cited by this paper
• Imaging tumor response following liver-directed intra-arterial therapy

  2013cited by this paper
• Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.

  2013influential reference
• Gastroduodenal ulceration following liver radioembolization with yttrium-90

  2013cited by this paper
• Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.

  2013cited by this paper
• Radioembolization for Treatment of Salvage Patients with Colorectal Cancer Liver Metastases: A Systematic Review

  2013cited by this paper
• Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response?

  2013cited by this paper
• 90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy

  2012cited by this paper
• Radioembolization for hepatocellular carcinoma.

  2012cited by this paper
• Image-Guided Personalized Predictive Dosimetry by Artery-Specific SPECT/CT Partition Modeling for Safe and Effective 90Y Radioembolization

  2012cited by this paper
• Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival

  2012cited by this paper
• Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.

  2012cited by this paper
• From the Angio Suite to the γ-Camera: Vascular Mapping and 99mTc-MAA Hepatic Perfusion Imaging Before Liver Radioembolization—A Comprehensive Pictorial Review

  2012cited by this paper
• Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review.

  2012influential reference
• Transarterial therapies for hepatocellular carcinoma

  2011cited by this paper
• Hepatic radioembolization complicated by fulminant hepatic failure.

  2011cited by this paper
• Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer

  2011cited by this paper
• General Selection Criteria of Patients for Radioembolization of Liver Tumors: An International Working Group Report

  2011cited by this paper
• Hepatic radioembolization complicated by radiation cholecystitis.

  2011cited by this paper
• Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.

  2011cited by this paper
• Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges.

  2011cited by this paper
• Gastroduodenal Ulceration Associated with Radioembolization for the Treatment of Hepatic Tumors: An Institutional Experience and Review of the Literature

  2010cited by this paper
• Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

  2010influential reference
• Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

  2010cited by this paper
• Diffusion-weighted MR imaging of the liver.

  2010cited by this paper
• Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT

  2009cited by this paper
• Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.

  2009influential reference
• Radiologic findings following Y90 radioembolization for primary liver malignancies

  2009influential reference
• Radiologic–pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium‐90 microspheres

  2009cited by this paper
• Yttrium-90 microsphere induced gastrointestinal tract ulceration

  2008cited by this paper
• Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.

  2008influential reference
• Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.

  2007influential reference
• Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

  2007cited by this paper
• Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET.

  2007cited by this paper
• Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation

  2006cited by this paper
• Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors.

  2003cited by this paper

• Radioembolization: Technical Tips and Follow-Up Imaging

  2025cites this paper
• An Uncommon Case of Severe Gastric Ulceration Following Radioembolization for Hepatocellular Carcinoma: Clinical Insights and Management Challenges

  2025cites this paper
• LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies.

  2025cites this paper
• Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma

  2025cites this paper
• Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects

  2024cites this paper
• New frontiers in radioembolization

  2024cites this paper
• Microfluidic Fabrication of Silica Microspheres Infused with Positron Emission Tomography Imaging Agents.

  2023cites this paper
• PET/CT with 18F-choline or 18F-FDG in Hepatocellular Carcinoma Submitted to 90Y-TARE: A Real-World Study

  2022cites this paper
• The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma

  2022cites this paper
• Radioembolization for hepatocellular carcinoma: what clinicians need to know

  2022cites this paper
• Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization

  2021cites this paper
• Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging

  2021cites this paper
• Evaluation of qualitative and quantitative data of Y-90 imaging in SPECT/CT and PET/CT phantom studies.

  2021cites this paper
• Artificial intelligence in assessment of hepatocellular carcinoma treatment response

  2021cites this paper
• Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma

  2021influential citation
• Technological challenges of theranostics in oncology

  2021cites this paper
• Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience.

  2021cites this paper
• Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience.

  2021cites this paper
• Remissionsparameter

  2021cites this paper
• Bildbasierte Charakterisierung maligner Lebertumoren und ihrer Tumormikroumgebung im Kontext lokoregionärer Therapien

  2021cites this paper
• Efficacy and safety of Yttrium-90 radioembolization in the treatment of neuroendocrine liver metastases. Long-term monitoring and impact on survival.

  2020cites this paper
• Combination of 1st and 2nd Week Dosing of Glass Yttrium-90 Microspheres for Superselective Radioembolization

  2020cites this paper
• Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material-enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging.

  2020cites this paper
• Radioembolization-induced Tumor Calcifications as a Surrogate Marker of Tumor Response in Patients With Hepatocellular Carcinoma

  2020cites this paper
• Evaluation of liver tumour response by imaging

  2020cites this paper
• Molecular and Metabolic Imaging of Hepatic Neuroendocrine Tumors Following Radioembolization with 90Y-microspheres.

  2020cites this paper
• Characteristics of Recent Articles Published in the Korean Journal of Radiology Based on the Citation Frequency

  2020cites this paper
• Selecting the Right Tool for the Right Job: Which Response Criteria Better Predicts Survival of Patients Treated with Transarterial Radioembolization?

  2020cites this paper
• Abdominal Manifestations of Neuroendocrine Tumors

  2019cites this paper
• Quantitative Imaging Biomarkers for 90Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization

  2019cites this paper
• Imaging Neuroendocrine Hepatic Metastases Following 90Y-Radioembolization: Is It Time to Implement Routine Use of PET Molecular/Metabolic Probes?

  2019cites this paper
• Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy

  2019cites this paper
• Efficacy and safety of Yttrium-90 radioembolization in the treatment of neuroendocrine liver metastases. Long-term monitoring and impact on survival

  year unknowncites this paper